GORE VIABAHN Endoprosthesis with Heparin VBHR091502ARecalls & reported problems
W. L. Gore & Associates, Inc. · GORE VIABAHN Endoprosthesis with Heparin 9mmx15cm 8Fr 120cmCath · Class 3 · Implant
All models of GORE VIABAHN Endoprosthesis with Heparin (62)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00733132646005), received between Sep 18, 2020 and Dec 19, 2025 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Activation Failure” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Activation Failure1
- Detachment of Device or Device Component1
- Physical Resistance/Sticking1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- No Code Available1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 19, 2025Activation Failure; Physical Resistance/Sticking; Activation Failure; Physical Resistance/Sticking
ON (B)(6) 2025, A PATIENT UNDERWENT AN ENDOVASCULAR PROCEDURE FOR AN ANEURYSM IN THE POPLITEAL ARTERY, UTILIZING A GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE. REPORTEDLY, THE DELIVERY SYSTEM CATHETER ADVANCED THROUGH A 10F SHEATH (BRAND UNKNOWN) OVER A .035" GLIDE ADVANTAGE GUIDEWIRE TO THE TARGET TREATMENT SITE. THE DELIVERY CATHETER SUCCESSFULLY REACHED THE INTENDED TREATMENT SITE. DURING DEPLOYMENT, THE DEPLOYMENT LINE WAS REPORTEDLY PULLED, AND THE DEPLOYMENT LINE APPEARED TO UNZIP FROM THE HUB UP TO THE TIP BUT THEN STOPPED. THERE WAS NO DISTAL EXPANSION OF THE ENDOPROSTHESIS INITIATED. THE PHYSICIAN WAS UNSURE OF THE CAUSE OF THE DEPLOYMENT FAILURE. THE DELIVERY CATHETER WAS PULLED BACK INTO THE INTRODUCER SHEATH AND WAS WITHDRAWN FROM THE PATIENT INTACT. THERE WAS NO IMPACT TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23856796 ↗InjurySep 18, 2020Detachment of Device or Device Component; Detachment of Device or Device Component
ON (B)(6) 2020, A GORE® VIABAHN® ENDOPROSTHESIS (VSX) WAS BEING PLACED AS A FENESTRATION DEVICE, IN THE MESENTERIC ARTERY. THE ACCESS WAS GAINED FROM THE ARM INTO THE SUBCLAVIAN ARTERY USING A 8.8FR COOK INTRODUCER SHEATH. AFTER THE PHYSICIAN ACCESSED THE MESENTERIC ARTERY, HE USED A TECHNIQUE OF RETRACTING THE SHEATH WHILE DEPLOYING THE DEVICE. WHEN HE THOUGHT THE DEVICE WAS FULLY DEPLOYED, HE ATTEMPTED TO REMOVE THE DEVICE CATHETER AND FELT SOME RESISTANCE. UNDER FLUOROSCOPY IT WAS NOTICED THAT THE DEVICE HAD BEEN PULLED BACK INTO THE AORTA. THE PHYSICIAN RETRACTED THE DEVICE TO THE INTRODUCER SHEATH AND ATTEMPTED TO REMOVE THE DEVICE AND SHEATH IN TANDEM. HOWEVER, WHEN THE DEVICE WAS BEING REMOVED IT HAD BECOME DEPLOYED IN THE SUBCLAVIAN ARCH. THE PHYSICIAN THAN HAD TO PERFORM A CUT DOWN PROCEDURE TO REMOVE THE DEVICE. AN ADDITIONAL VSX DEVICE WAS SUCCESSFULLY DEPLOYED TO COMPLETE THE PROCEDURE. THE PATIENT TOLERATED THE PROCEDURE.
Patient problems: No Code Available
MAUDE report 10554343 ↗
Other System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment devices
- COVERA AVSM10060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall33 reports
- COVERA AVSM08060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall21 reports
- COVERA AVSM09060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall18 reports
- COVERA AVSM10080Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall16 reports
- COVERA AVSM10040Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall15 reports
- COVERA AVFM10060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall14 reports
- COVERA AVSM09080Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall1 death14 reports
- COVERA AVSM10100Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall13 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page